Pre-clinical blocking of PD-L1 molecule, which expression is down regulated by NF-κB, JAK1/JAK2 and BTK inhibitors, induces regression of activated B-cell lymphoma

類似資料

• Pre-clinical blocking of PD-L1 molecule, which expression is down regulated by NF-κB, JAK1/JAK2 and BTK inhibitors, induces regression of activated B-cell lymphoma
  著者:: Vincent-Fabert, Christelle, 等
  出版事項: (2019)
• Reproducing indolent B-cell lymphoma transformation with T-cell immunosuppression in LMP1/CD40-expressing mice
  著者:: Vincent-Fabert, Christelle, 等
  出版事項: (2019)
• Inflamed phenotype of splenic marginal zone B-cell lymphomas with expression of PD-L1 by intratumoral monocytes/macrophages and dendritic cells
  著者:: Vincent-Fabert, Christelle, 等
  出版事項: (2019)
• c-Myc dysregulation is a co-transforming event for nuclear factor-κB activated B cells
  著者:: David, Amandine, 等
  出版事項: (2017)
• EBV Latency III–Transformed B Cells Are Inducers of Conventional and Unconventional Regulatory T Cells in a PD-L1–Dependent Manner
  著者:: Auclair, Héloïse, 等
  出版事項: (2019)